Status:

COMPLETED

A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

Lead Sponsor:

Alcon Research

Conditions:

Open-angle Glaucoma

Ocular Hypertension

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

The purpose of this study is to assess the comfort of a glaucoma therapy in patients with open-angle glaucoma or ocular hypertension

Eligibility Criteria

Inclusion

  • Adults of either sex and any race diagnosed with open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component)

Exclusion

  • Under 18

Key Trial Info

Start Date :

May 1 2006

Trial Type :

INTERVENTIONAL

End Date :

August 1 2006

Estimated Enrollment :

88 Patients enrolled

Trial Details

Trial ID

NCT00326092

Start Date

May 1 2006

End Date

August 1 2006

Last Update

November 18 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Fort Worth and Other Sites

Fort Worth, Texas, United States, 76134